Cetuximab-based or bevacizumab-based first-line treatment in patients with KRAS p.G13D-mutated metastatic colorectal cancer: a pooled analysis (Q43723138)
Jump to navigation
Jump to search
scientific article published in July 2012
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Cetuximab-based or bevacizumab-based first-line treatment in patients with KRAS p.G13D-mutated metastatic colorectal cancer: a pooled analysis |
scientific article published in July 2012 |
Statements
1 reference
Cetuximab-based or bevacizumab-based first-line treatment in patients with KRAS p.G13D-mutated metastatic colorectal cancer: a pooled analysis (English)
1 reference
Anke Reinacher-Schick
1 reference
Wolff Schmiegel
1 reference
Dominik Paul Modest
1 reference
Sebastian Stintzing
1 reference
Clemens Giessen
1 reference
Andrea Tannapfel
1 reference
Ruediger Paul Laubender
1 reference
Thomas Brodowicz
1 reference
Regina Knittelfelder
1 reference
Damir Vrbanec
1 reference
Volker Heinemann
1 reference
Christoph C Zielinski
1 reference
1 July 2012
1 reference
1 reference
Identifiers
1 reference